BASHH UK guidelines for the management of syphilis 2024
The DOI matches its Crossref record; 124 of the 124 references it cites were found in a registry or an index; 53 of the 183 sources its claims cite were checked for support.
Abstract
The 2024 UK guidelines for the management of syphilis are in line with current evidence and practice within the UK. Key updates are detailed at the start of the article. These guidelines are accompanied by the first UK guidelines for the management of syphilis in pregnant people and children, 2024.
Overview
CoChat Summary
TL;DR
The 2024 BASHH UK guidelines update recommendations for diagnosing and managing syphilis in people aged 16 and over in UK specialist sexual health services, with key changes including licensed benzathine penicillin with lidocaine, withdrawal of macrolides due to resistance, ceftriaxone as a penicillin alternative, expanded PCR use, and revised serology, lumbar puncture and treatment-interruption advice. They are accompanied by the first UK guidelines for syphilis in pregnant people and children.
Key findings
- Macrolides are no longer recommended for syphilis treatment due to antimicrobial resistance (point mutation at A2058G or A2059G in the 23S rRNA gene) and poor placental/blood–brain barrier penetration; benzathine penicillin G remains first-line, with penicillin resistance never reported.
- Benzathine penicillin diluted with lidocaine is now licensed in the UK and is the recommended preparation; ceftriaxone is an alternative appropriate in most cases where penicillin cannot be used.
- Routine CSF assessment in patients without symptomatic disease is not recommended (1A); CSF examination is indicated with clinical neurological involvement except ophthalmic or otological syphilis, where it is rarely useful (1C). CSF RPR is 51%–82% sensitive and 82%–100% specific; CSF TPHA titre >1:320 is sensitive and specific for neurosyphilis.
- Epidemiology cited: England 2019 had 7982 infectious syphilis cases, 5875 (74%) in GBMSM, 43% of whom were living with HIV; by 2019 diagnoses in women rose 135% to 597 and doubled in men to 1016. Approximately one-third of sexual contacts of infectious syphilis develop disease (transmission rates 10%–60%), and 46%–60% of contactable partners of early syphilis cases are infected.
- Treatment interruption: a single 2.4 MU benzathine penicillin G dose gives treponemicidal levels for 2–4 weeks, so subsequent doses within 14 days of the previous dose do not require restarting; for neurosyphilis, interruption >24 h requires restarting the course (1B).
Methods
- Guideline development by a writing group following the BASHH Framework for Guideline Development, with an equality impact assessment using the NICE tool, CEG review, 2-month public consultation on the BASHH website, and piloting by target users and the BASHH public panel.
- Systematic literature review of Medline, Embase and the Cochrane library for English-language publications January 2014–December 2020, using 11 defined search strings covering partner notification, treatment, serology, PCR, point-of-care tests, neurosyphilis diagnosis, typing and whole genome sequencing; previous UK and US guidelines were also reviewed.
- Recommendations are graded (e.g. 1A–2D) and cover diagnosis, treatment regimens, partner notification, follow-up and auditable outcomes (e.g. 97% standards for RPR titre at treatment, treatment adherence and contact action documentation; 65% for RPR titre at 6 months).
Limitations
- Stated: robust evidence for optimal management of complications and tertiary syphilis is lacking, so recommendations rest mainly on laboratory considerations, biological plausibility, expert opinion, case studies and clinical experience; there is very little evidence on the recommended duration of sexual abstinence after treatment.
- Stated: no diagnostic gold standard for neurosyphilis means studies use differing definitions, limiting the strength of the evidence base; evidence for T. pallidum PCR in neurosyphilis is weak (small, heterogeneous studies).
- Stated: the recommendations may not be appropriate in all clinical situations and decisions must rest on clinician judgement, individual patient circumstances and available resources; the guidelines target people aged 16+ in UK specialist STI care, though principles should be adopted across care levels.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
39 Valid · 15 Not valid · 37 Not checked · 16 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“HIV infection does not appear to affect the mucocutaneous manifestations of secondary syphilis.22,23”
What the sources say
- Not checked — no full text of the sourcecites [22] matched to “Clinical Manifestations of Early Syphilis by HIV Status and Gender: Results of the Syphilis and HIV Study” (2001) source
- Partly supportedcites [23] matched to “Secondary Syphilitic Lesions” (2005) sourceExperimental — accuracy not yet measured
The Introduction says there is little to suggest that dermatologic manifestations of secondary syphilis are more striking in people with HIV, supporting the claim's qualified point about skin manifestations. It does not make the same comparison for mucosal lesions or establish that HIV has no effect on mucocutaneous manifestations overall. (LLM, conf=0.84)
hedged- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Untreated, 25% of patients will develop signs of secondary syphilis approximately 3–10 weeks after the appearance of the initial chancre .23,24”
What the sources say
- Partly supportedcites [23] matched to “Secondary Syphilitic Lesions” (2005) sourceExperimental — accuracy not yet measured
The Introduction says secondary-stage lesions generally appear 4–10 weeks after primary lesions first appear, broadly supporting the timing but not the stated 3–10 weeks. Its ‘Early Latency, Relapses, or Recurrent Secondary Eruptions’ section applies the 25% figure to patients whose infection had become latent and who experienced a recurrence within 12 months, not to patients first developing secondary syphilis. (LLM, conf=0.90)
- Not matchedcites [24]
The reference list we hold has no entry [24].
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“A positive IgM result may be useful if primary or congenital syphilis is suspected.”
What the sources say
- Not checked — no full text of the sourcecites [49] matched to “2014 European guideline on the management of syphilis” (2014) source
- Supportedcites [50] matched to “Role of IgM testing in the diagnosis and post-treatment follow-up of syphilis: a prospective cohort study” (2020) source
The Introduction (page not provided) says early IgM detection could help diagnose early syphilis and reports that European guidelines consider IgM testing useful in assessing newborns. This supports the claim’s cautious wording, though the paper notes that a negative IgM result cannot exclude congenital syphilis and that evidence for its utility in newborns is limited. (LLM, conf=0.88)
- Not checked — no full text of the sourcecites [51] matched to “Utility of antitreponemal IgM testing in the diagnosis of early and repeat syphilis among HIV-infected and non-infected patients” (2018) source
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Rapid point-of-care tests using finger prick blood samples are useful for on-site testing in outreach settings, provided positive results are confirmed by laboratory tests.”
What the sources say
- Partly supportedcites [52] matched to “Use of Oral Fluid With a Rapid Treponemal Test for Syphilis Evaluation” (2018) sourceExperimental — accuracy not yet measured
The Note section (page not provided) says rapid point-of-care syphilis tests use finger-prick whole blood and enable same-day testing and treatment. It does not specifically establish their usefulness in outreach settings or say that positive finger-prick results must be confirmed by laboratory tests; its discussion of combining test results concerns syphilis diagnosis generally. (LLM, conf=0.86)
plainstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“A positive CSF TPHA test is highly sensitive for neurosyphilis”
What the sources say
- Partly supportedcites [73] matched to “Evaluation of theTreponema pallidum particle agglutination technique (TP.PA) in the diagnosis of neurosyphilis” (2006) sourceExperimental — accuracy not yet measured
The Results report that CSF TP.PA was reactive in all 16 patients classified as having neurosyphilis, and Table 3 shows MHA-TP was reactive in 15 of 16. The paper does not report sensitivity for a CSF TPHA test: its Introduction mentions only a TPHA index, while the measured tests were TP.PA and MHA-TP. Thus the claim is consistent with the paper’s findings for related tests, but attributes them to a different test. (LLM, conf=0.85)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
60 more claims · 24 with their cited sources checked
Create a free account to see all 107 claims and every source verdict.
- It may state two separate claims as one. 29
- Probably not a substantial claim. 24
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ 2 International Journal of STD & AIDS 0(0)
“General paresis: this is a progressive dementing illness that occurs 10–25 years after infection secondary to cortical neuronal loss.”
§ 2 International Journal of STD & AIDS 0(0)
“• General paresis 10–20 years Cortical neuronal loss”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ 2 International Journal of STD & AIDS 0(0)
“Meningovascular syphilis typically occurs 5–10 years after infection (but sometimes earlier).”
§ 2 International Journal of STD & AIDS 0(0)
“Meningovascular 0–7 years Focal arteritis inducing infarction/meningeal inflammation”
Citations
Cites
Peeling, R. W., Mabey, D., Kamb, M. L., Chen, X.-S., Radolf, J. D., & Benzaken, A. S. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.73 · Cited by 664
Syphilis: Review with Emphasis on Clinical, Epidemiologic, and Some Biologic Features
Singh, A. E., & Romanowski, B. (1999) · Clinical Microbiology Reviews · doi:10.1128/cmr.12.2.187 · Cited by 638
LaFond, R. E., & Lukehart, S. A. (2006) · Clinical Microbiology Reviews · doi:10.1128/cmr.19.1.29-49.2006 · Cited by 634
Lukehart, S. A., Hook, E. W., Baker-Zander, S. A., Collier, A. C., Critchlow, C. W., & Handsfield, H. H. (1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-109-11-855 · Cited by 603 · cited 1×
“83 · If treatment for neurosyphilis is interrupted for more than 24 h the course should be re-started; this is because of the need to maintain continuous CSF treponemicidal levels of treatment throughout the course.”
BackgroundRolfs, R. T., Joesoef, M. R., Hendershot, E. F., Rompalo, A. M., Augenbraun, M. H., Chiu, M., Bolan, G., Johnson, S. C., French, P., Steen, E., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199707313370504 · Cited by 550
Marra, C. M., Maxwell, C. L., Smith, S. L., Lukehart, S. A., Rompalo, A. M., Eaton, M., Stoner, B. P., Augenbraun, M., Barker, D. E., Corbett, J. J., et al. (2004) · The Journal of Infectious Diseases · doi:10.1086/381227 · Cited by 491
Hook, E. W., & Marra, C. M. (1992) · New England Journal of Medicine · doi:10.1056/nejm199204163261606 · Cited by 470
Syphilis and HIV: a dangerous combination
Lynn, W., & Lightman, S. (2004) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(04)01061-8 · Cited by 450
Hook, E. W. (2017) · The Lancet · doi:10.1016/s0140-6736(16)32411-4 · Cited by 446
2020 European guideline on the management of syphilis
Janier, M., Unemo, M., Dupin, N., Tiplica, G. S., Potočnik, M., & Patel, R. (2021) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.16946 · Cited by 421
Macrolide Resistance in Treponema pallidum in the United States and Ireland
Lukehart, S. A., Godornes, C., Molini, B. J., Sonnett, P., Hopkins, S., Mulcahy, F., Engelman, J., Mitchell, S. J., Rompalo, A. M., Marra, C. M., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040216 · Cited by 378 · cited 1×
“123 – 125 Follow-up”
2014 European guideline on the management of syphilis
Janier, M., Hegyi, V., Dupin, N., Unemo, M., Tiplica, G. S., Potočnik, M., French, P., & Patel, R. (2014) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.12734 · Cited by 360
Single-dose azithromycin versus penicillin G benzathine for the treatment of early syphilis.
Riedner, G., Rusizoka, M., Todd, J., Maboko, L., Hoelscher, M., Mmbando, D., Samky, E., Lyamuya, E., Mabey, D., Grosskurth, H., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa044284 · Cited by 296 · cited 1×
“123 – 125 Follow-up”
INOCULATION SYPHILIS IN HUMAN VOLUNTEERS
MAGNUSON, H. J., THOMAS, E. W., OLANSKY, S., KAPLAN, B. I., MELLO, L. D., & CUTLER, J. C. (1956) · Medicine · doi:10.1097/00005792-195602000-00002 · Cited by 273
UK national guidelines on the management of syphilis 2015
Kingston, M., French, P., Higgins, S., McQuillan, O., Sukthankar, A., Stott, C., McBrien, B., Tipple, C., Turner, A., Sullivan, A., et al. (2016) · International Journal of STD & AIDS · doi:10.1177/0956462415624059 · Cited by 267
Self-citationPenicillin Allergy and Desensitization in Serious Infections during Pregnancy
Wendel, G. D., Stark, B. J., Jamison, R. B., Molina, R. D., & Sullivan, T. J. (1985) · New England Journal of Medicine · doi:10.1056/nejm198505093121905 · Cited by 262
Baughn, R. E., & Musher, D. M. (2005) · Clinical Microbiology Reviews · doi:10.1128/cmr.18.1.205-216.2005 · Cited by 252 · cited 5×
“23,27,33,35 38 Previous infection does not confer immunity and individuals are susceptible to re-infection.”
InfluentialRisk factors for syphilis: cocaine use and prostitution.
Rolfs, R. T., Goldberg, M., & Sharrar, R. G. (1990) · American Journal of Public Health · doi:10.2105/ajph.80.7.853 · Cited by 241
Neurosyphilis: A Study of 241 Patients
Hooshmand, H. (1972) · JAMA · doi:10.1001/jama.1972.03190320032011 · Cited by 215
Neurosyphilis in a clinical cohort of HIV-1-infected patients.
Ghanem, K. G., Moore, R. D., Rompalo, A. M., Erbelding, E. J., Zenilman, J. M., & Gebo, K. A. (2008) · AIDS · doi:10.1097/qad.0b013e32830184df · Cited by 212
ROMPALO, A. M., JOESOEF, M. R., O???DONNELL, J. A., AUGENBRAUN, M., BRADY, W., RADOLF, J. D., JOHNSON, R., & ROLFS, R. T. (2001) · Sex Transm Dis · doi:10.1097/00007435-200103000-00007 · Cited by 211
Marra, C. M., Boutin, P., McArthur, J. C., Hurwitz, S., Simpson, G., Haslett, J. P. A., van der Horst, C., Nevin, T., Hook, E. W., & AIDS Clinical Trials Group (ACTG) 145 Team (2000) · Clinical Infectious Diseases · doi:10.1086/313725 · Cited by 194
The Signs and Symptoms of Secondary Syphilis
CHAPEL, T. A. (1980) · Sexually Transmitted Diseases · doi:10.1097/00007435-198010000-00002 · Cited by 193
Neurosyphilis and Penicillin Levels in Cerebrospinal Fluid
Mohr, J. A. (1976) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1976.03270200046031 · Cited by 178
Transplacental Passage of Erythromycin and Clindamycin
Philipson, A., Sabath, L. D., & Charles, D. (1973) · New England Journal of Medicine · doi:10.1056/nejm197306072882307 · Cited by 160 · cited 1×
“123 – 125 Follow-up”
Marra, C. M., Maxwell, C. L., Tantalo, L. C., Sahi, S. K., & Lukehart, S. A. (2008) · Clinical Infectious Diseases · doi:10.1086/591534 · Cited by 159
Seña, A. C., Zhang, X.-H., Li, T., Zheng, H.-P., Yang, B., Yang, L.-G., Salazar, J. C., Cohen, M. S., Moody, M. A., Radolf, J. D., et al. (2015) · BMC Infectious Diseases · doi:10.1186/s12879-015-1209-0 · Cited by 150
Use of PCR in the diagnosis of early syphilis in the United Kingdom
Palmer, H. M. (2003) · Sexually Transmitted Infections · doi:10.1136/sti.79.6.479 · Cited by 150 · cited 1×
“· Molecular diagnostics 41 – 43 : o Commercial assays are available for the molecular detection of T. pallidum o Polymerase chain reaction (PCR) has been shown to have higher sensitivity and speci fi city than dark ground microscopy and can be used on oral or other lesions where commensal treponemes…”
MethodBeale, M. A., Marks, M., Cole, M. J., Lee, M.-K., Pitt, R., Ruis, C., Balla, E., Crucitti, T., Ewens, M., Fernández-Naval, C., et al. (2021) · Nature Microbiology · doi:10.1038/s41564-021-01000-z · Cited by 135 · cited 1×
“115 – 117 · Treatment of neurosyphilis in patients with signi fi cant penicillin allergy is challenging, and penicillin desensi-tisation is probably the best option.”
BackgroundSelf-citationSyphilis transmission: a review of the current evidence
Stoltey, J. E., & Cohen, S. E. (2015) · Sexual Health · doi:10.1071/sh14174 · Cited by 135
Yim, C. W., Flynn, N. M., & Fitzgerald, F. T. (1985) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.28.2.347 · Cited by 133
Dowell, M. E., Ross, P. G., Musher, D. M., Cate, T. R., & Baughn, R. E. (1992) · The American Journal of Medicine · doi:10.1016/0002-9343(92)90574-u · Cited by 133 · cited 1×
“123 – 125 Follow-up”
Impact of Syphilis Infection on HIV Viral Load and CD4 Cell Counts in HIV-Infected Patients
Palacios, R., Jiménez-Oñate, F., Aguilar, M., Galindo, M. J., Rivas, P., Ocampo, A., Berenguer, J., Arranz, J. A., Ríos, M. J., Knobel, H., et al. (2007) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e31802ea4c6 · Cited by 133
Sexually Transmitted Infections Treatment Guidelines, 2021
Niforatos, J. D., & Rothman, R. E. (2022) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2022.05.017 · Cited by 129
Doxycycline compared with benzathine penicillin for the treatment of early syphilis.
Ghanem, K. G., Erbelding, E. J., Cheng, W. W., & Rompalo, A. M. (2006) · Clinical Infectious Diseases · doi:10.1086/500406 · Cited by 125
Harding, A. S., & Ghanem, K. G. (2012) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e31824c0e62 · Cited by 125
Syphilis laboratory guidelines: performance characteristics of nontreponemal antibody tests.
Tuddenham, S., Katz, S. S., & Ghanem, K. G. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa306 · Cited by 124
Stamm, L. V., & Bergen, H. L. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.3.806-807.2000 · Cited by 123 · cited 1×
“123 – 125 Follow-up”
Hook III, E. W., Behets, F., Van Damme, K., Ravelomanana, N., Leone, P., Sena, A. C., Martin, D., Langley, C., McNeil, L., & Wolff, M. (2010) · The Journal of Infectious Diseases · doi:10.1086/652239 · Cited by 121
Gaudio, P. A. (2006) · Current Opinion in Ophthalmology · doi:10.1097/icu.0b013e328010a9b5 · Cited by 118
Modification of Syphilitic Genital Ulcer Manifestations by Coexistent HIV Infection
ROMPALO, A. M., LAWLOR, J., SEAMAN, P., QUINN, T. C., ZENILMAN, J. M., & HOOK, E. W. (2001) · Sexually Transmitted Diseases · doi:10.1097/00007435-200108000-00004 · Cited by 115
Marra, C. M., Tantalo, L. C., Maxwell, C. L., Ho, E. L., Sahi, S. K., & Jones, T. (2012) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e31824b1cde · Cited by 114
Eagle, H., Fleischman, R., & Musselman, A. D. (1950) · Journal of Bacteriology · doi:10.1128/jb.59.5.625-643.1950 · Cited by 114
Leslie, D. E., Azzato, F., Karapanagiotidis, T., Leydon, J., & Fyfe, J. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.01578-06 · Cited by 111 · cited 1×
“· Where appropriate expertise and equipment are available, dark ground microscopy should be performed on possible chancres: 2A.”
Ghanem, K. G., Moore, R. D., Rompalo, A. M., Erbelding, E. J., Zenilman, J. M., & Gebo, K. A. (2008) · Clinical Infectious Diseases · doi:10.1086/589295 · Cited by 105 · cited 1×
“133 · Diagnosis of neurosyphilis in people living with HIV is complicated by pleocytosis and elevated CSF protein levels seen in individuals with asymptomatic HIV.”
BackgroundFactors Determining Serologic Response to Treatment in Patients with Syphilis
González‐López, J. J., Guerrero, M. L. F., Luján, R., Tostado, S. F., de Górgolas, M., & Requena, L. (2009) · Clinical Infectious Diseases · doi:10.1086/644618 · Cited by 97
Otosyphilis: A review of 85 cases
Yimtae, K., Srirompotong, S., & Lertsukprasert, K. (2007) · Otolaryngology–Head and Neck Surgery · doi:10.1016/j.otohns.2006.08.026 · Cited by 92
Gastric Syphilis: A Systematic Review of Published Cases of the Last 50 Years
Mylona, E. E., Baraboutis, I. G., Papastamopoulos, V., Tsagalou, E. P., Vryonis, E., Samarkos, M., Fanourgiakis, P., & Skoutelis, A. T. (2010) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e3181c0d51f · Cited by 90
Ceftriaxone Therapy for Incubating and Early Syphilis
Hook, E. W., Roddy, R. E., & Hanosfield, H. H. (1988) · The Journal of Infectious Diseases · doi:10.1093/infdis/158.4.881 · Cited by 88
Interpreting cerebrospinal fluid pleocytosis in HIV in the era of potent antiretroviral therapy
Marra, C. M., Maxwell, C. L., Collier, A. C., Robertson, K. R., & Imrie, A. A. (2007) · BMC Infectious Diseases · doi:10.1186/1471-2334-7-37 · Cited by 88
Significance of laboratory findings for the diagnosis of neurosyphilis
Luger, A. F., Schmidt, B. L., & Kaulich, M. (2000) · International Journal of STD & AIDS · doi:10.1258/0956462001915750 · Cited by 87
High Incidence of Asymptomatic Syphilis in HIV-Infected MSM Justifies Routine Screening
Branger, J., van der Meer, J. T. M., van Ketel, R. J., Jurriaans, S., & Prins, J. M. (2009) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e318186debb · Cited by 84
The Prozone Phenomenon with Syphilis and HIV-1 Co-infection
Smith, G., & Holman, R. P. (2004) · Southern Medical Journal · doi:10.1097/01.smj.0000121204.58881.60 · Cited by 78
Dark ground microscopy and treponemal serological tests in the diagnosis of early syphilis
Wheeler, H. L. (2004) · Sexually Transmitted Infections · doi:10.1136/sti.2003.008821 · Cited by 78 · cited 1×
“Demonstration of T. pallidum using direct detection methods · Dark ground microscopy: 40 o Gives immediate results o Should be performed only by experienced observers as it is subjective and may lead to false-positive or false-negative results o Is less reliable in examining rectal and non-penile…”
MethodTreatment of neurosyphilis with ceftriaxone.
Shann, S. (2003) · Sexually Transmitted Infections · doi:10.1136/sti.79.5.415 · Cited by 76
Bone Involvement in Secondary Syphilis: A Case Report and Systematic Review of the Literature
Park, K., Lee, M. S., Hong, I. K., Sung, J., Choi, S., Park, S. O., Shin, M. J., Chung, H. W., & Lee, S. H. (2014) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000000164 · Cited by 74
Smith, N. H., Musher, D. M., Huang, D. B., Rodriguez, P. S., Dowell, M. E., Ace, W., & White, A. C. (2004) · International Journal of STD & AIDS · doi:10.1177/095646240401500511 · Cited by 74
Towns, J. M., Leslie, D. E., Denham, I., Azzato, F., Fairley, C. K., & Chen, M. (2016) · Sexually Transmitted Infections · doi:10.1136/sextrans-2015-052219 · Cited by 71
Rolfs, R. T. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/20.supplement_1.s23 · Cited by 70
Molecular detection of Treponema pallidum in secondary and tertiary syphilis
ZOECHLING, N., SCHLUEPEN, E. M., SOYER, H. P., KERL, H., & VOLKENANDT, M. (1997) · British Journal of Dermatology · doi:10.1046/j.1365-2133.1997.6561614.x · Cited by 68
HOOK, E. W., BAKER-ZANDER, S. A., MOSKOVITZ, B. L., LUKEHART, S. A., & HANDSFIELD, H. H. (1986) · Sexually Transmitted Diseases · doi:10.1097/00007435-198607000-00018 · Cited by 66
Specific and sensitive diagnosis of syphilis using a real-time PCR for Treponema pallidum
Koek, A. G., Bruisten, S. M., Dierdorp, M., van Dam, A. P., & Templeton, K. (2006) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2006.01566.x · Cited by 61
Diagnostic performance of PCR assays for the diagnosis of neurosyphilis: a systematic review
Marks, M., Lawrence, D. S., Kositz, C., & Mabey, D. C. W. (2018) · Sexually Transmitted Infections · doi:10.1136/sextrans-2018-053666 · Cited by 59
Clinical Manifestations of Secondary Syphilis
Hira, S. K., Patel, J. S., Bhat, S. G., Chilikima, K., & Mooney, N. (1987) · International Journal of Dermatology · doi:10.1111/j.1365-4362.1987.tb00532.x · Cited by 59
Clinical Features and Treatments of Syphilitic Uveitis: A Systematic Review and Meta-Analysis
Zhang, T., Zhu, Y., & Xu, G. (2017) · Journal of Ophthalmology · doi:10.1155/2017/6594849 · Cited by 59
2012 BASHH statement on partner notification for sexually transmissible infections
McClean, H., Radcliffe, K. W., Sullivan, A. K., & Ahmed-Jushuf, I. H. (2013) · International Journal of STD & AIDS · doi:10.1177/0956462412472804 · Cited by 58
Self-citationGanesan, A., Mesner, O., Okulicz, J. F., O'Bryan, T., Deiss, R. G., Lalani, T., Whitman, T. J., Weintrob, A. C., Macalino, G., & Agan, B. K. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/ciu888 · Cited by 54
Ceftriaxone for Treatment of Primary Syphilis in Men: A Preliminary Study
MOORTHY, T. T., LEE, C.-T., LIM, K.-B., & TAN, T. (1987) · Sexually Transmitted Diseases · doi:10.1097/00007435-198704000-00013 · Cited by 52
Syphilis and blood transfusion: a global perspective
de Schryver, A., & Meheus, A. Z. (1990) · Transfusion · doi:10.1046/j.1537-2995.1990.30991048793.x · Cited by 52
Syphilis Treatment Response Among HIV-Discordant Couples in Zambia and Rwanda
Dionne-Odom, J., Karita, E., Kilembe, W., Henderson, F., Vwalika, B., Bayingana, R., Li, Z., Mulenga, J., Chomba, E., del Rio, C., et al. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit146 · Cited by 52
Cao, Y., Su, X., Wang, Q., Xue, H., Zhu, X., Zhang, C., Jiang, J., Qi, S., Gong, X., Zhu, X., et al. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix611 · Cited by 51 · cited 1×
“102,103 104 – 113 · Linezolid has been shown to be an effective treatment in animal models of syphilis but there have been no human trials to date.”
BackgroundFarhi, D., Benhaddou, N., Grange, P., Zizi, N., Deleuze, J., Morini, J.-P., Gerhardt, P., Krivine, A., Avril, M.-F., & Dupin, N. (2009) · Medicine · doi:10.1097/md.0b013e3181c2af86 · Cited by 50
Syphilitic Coronary Artery Ostial Stenosis Resulting in Acute Myocardial Infarction and Death
Kennedy, J. L. W., Barnard, J. J., & Prahlow, J. A. (2005) · Cardiology · doi:10.1159/000088337 · Cited by 50
Immunological Diagnosis of Sexually Transmitted Diseases
TAYLOR‐ROBINSON, D. (1988) · Journal of Clinical Pathology · doi:10.1136/jcp.41.5.599-e · Cited by 50
Tsai, J.-C., Lin, Y.-H., Lu, P.-L., Shen, N.-J., Yang, C.-J., Lee, N.-Y., Tang, H.-J., Liu, Y.-M., Huang, W.-C., Lee, C.-H., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0109813 · Cited by 49 · cited 1×
“94 For all stages of syphilis, there is no evidence to suggest that people living with HIV need to be treated differently compared to HIV-negative individuals 134 – 138 : 1B. · Prolonged treatment or additional antibiotic therapy has not been associated with signi fi cantly better outcomes.”
BackgroundCerebrospinal Fluid Penicillin Levels During Therapy for Latent Syphilis
Ducas, J. (1981) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1981.03320220033020 · Cited by 48
Efficacy of linezolid on Treponema pallidum, the syphilis agent: A preclinical study
Haynes, A. M., Giacani, L., Mayans, M. V., Ubals, M., Nieto, C., Pérez-Mañá, C., Quintó, L., Romeis, E., & Mitjà, O. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2021.103281 · Cited by 47
Lumbar Puncture in Asymptomatic Late Syphilis: An Analysis of the Benefits and Risks
Wiesel, J. (1985) · Archives of Internal Medicine · doi:10.1001/archinte.1985.00360030105020 · Cited by 47
Rekart, M. L., Ndifon, W., Brunham, R. C., Dushoff, J., Park, S. W., Rawat, S., & Cameron, C. E. (2017) · Sexually Transmitted Infections · doi:10.1136/sextrans-2016-052870 · Cited by 45
Neurosyphilis is Unlikely in Patients with Late Latent Syphilis and a Negative Blood VDRL-Test
Wöhrl, S., & Geusau, A. (2006) · Acta Dermato-Venereologica · doi:10.2340/00015555-0092 · Cited by 45
Meta-analysis of ceftriaxone compared with penicillin for the treatment of syphilis
Liang, Z., Chen, Y.-P., Yang, C.-S., Guo, W., Jiang, X.-X., Xu, X.-F., Feng, S.-X., Liu, Y.-Q., & Jiang, G. (2016) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2015.10.020 · Cited by 44
Previous Syphilis Alters the Course of Subsequent Episodes of Syphilis
Marra, C. M., Maxwell, C. L., Sahi, S. K., Tantalo, L. C., Dunaway, S. B., & Lukehart, S. A. (2022) · Clinical Infectious Diseases · doi:10.1093/cid/ciab287 · Cited by 43
Penicillin Desensitization in the Treatment of Syphilis During Pregnancy
Chisholm, C., Katz, V., McDonald, T., & Bowes, Jr. (1997) · American Journal of Perinatology · doi:10.1055/s-2007-994332 · Cited by 41
Production of treponemicidal concentration of penicillin in cerebrospinal fluid.
DUNLOP, E. M. C., Al-Egaily, S. S., & Houang, E. T. (1981) · BMJ · doi:10.1136/bmj.283.6292.646 · Cited by 40
Detection of Treponema pallidum in the vitreous by PCR
Müller, M., Ewert, I., Hansmann, F., Tiemann, C., Hagedorn, H., Solbach, W., Roider, J., Nölle, B., Laqua, H., & Hoerauf, H. (2006) · British Journal of Ophthalmology · doi:10.1136/bjo.2006.110288 · Cited by 40
Otosyphilis: A diagnostic and therapeutic dilemma
Gleich, L. L., Linstrom, C. J., & Kimmelman, C. P. (1992) · The Laryngoscope · doi:10.1288/00005537-199211000-00010 · Cited by 40
Surfing with spirochaetes: an ongoing syphilis outbreak in Brighton
Poulton, M. (2001) · Sexually Transmitted Infections · doi:10.1136/sti.77.5.319 · Cited by 39
Jarisch-Herxheimer reaction in a patient with neurosyphilis.
Zifko, U., Lindner, K., Wimberger, D., Volc, B., & Grisold, W. (1994) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.57.7.865 · Cited by 37
Andrade, R., Rodriguez-Barradas, M. C., Yasukawa, K., Villarreal, E., Ross, M., & Serpa, J. A. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/ciw862 · Cited by 35
Castro, R., Prieto, E. S., João Águas, M., José Manata, M., Botas, J., Araújo, C., Borges, F., Aldir, I., & Exposto, F. D. L. (2006) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.20147 · Cited by 35
Inagaki, H., Kawai, T., Miyata, M., Nagaya, S., Tateyama, H., & Eimoto, T. (1996) · Human Pathology · doi:10.1016/s0046-8177(96)90446-3 · Cited by 34
Levchik, N., Ponomareva, M., Surganova, V., Zilberberg, N., & Kungurov, N. (2013) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000000049 · Cited by 34
Kenyon, C., Tsoumanis, A., Osbak, K., Van Esbroeck, M., Florence, E., Crucitti, T., & Kestens, L. (2018) · Sexually Transmitted Infections · doi:10.1136/sextrans-2017-053312 · Cited by 32
Löwhagen, G., Brorson, J., & Kaijser, B. (1983) · Acta Dermato-Venereologica · doi:10.2340/00015555635357 · Cited by 32
Ceftriaxone Therapy for Syphilis: Report from the Emerging Infections Network
Augenbraun, M., & Workowski, K. (1999) · Clinical Infectious Diseases · doi:10.1086/313489 · Cited by 32
Clinical Aspects of Syphilis Reinfection in HIV-Infected Patients
Courjon, J., Hubiche, T., Dupin, N., Grange, P. A., & Del Giudice, P. (2015) · Dermatology · doi:10.1159/000369617 · Cited by 31 · cited 1×
“23,27,33,35 38 Previous infection does not confer immunity and individuals are susceptible to re-infection.”
BackgroundSanchez, A., Mayslich, C., Malet, I., Grange, P., Janier, M., Saule, J., Martinet, P., Robert, J., Moulene, D., Truchetet, F., et al. (2020) · Acta Dermato Venereologica · doi:10.2340/00015555-3589 · Cited by 31
Molecular Typing of Treponema pallidum in Denmark: A Nationwide Study of Syphilis
Salado-Rasmussen, K., Cowan, S., Gerstoft, J., Larsen, H., Hoffmann, S., Knudsen, T., Katzenstein, T., & Jensen, J. (2016) · Acta Dermato Venereologica · doi:10.2340/00015555-2190 · Cited by 30
Hahn, R. D. (1956) · A M A Archives of Dermatology · doi:10.1001/archderm.1956.01550100023006 · Cited by 30
Evaluation of Aqueous Penicillin G and Ceftriaxone for Experimental Neurosyphilis
Marra, C. M., Slatter, V., Tartaglione, T. A., Baker-Zander, S. A., & Lukehart, S. A. (1992) · Journal of Infectious Diseases · doi:10.1093/infdis/165.2.396 · Cited by 27
Tomkins, A., Ahmad, S., Cousins, D. E., Thng, C. M., Vilar, F. J., & Higgins, S. P. (2018) · Sexually Transmitted Infections · doi:10.1136/sextrans-2016-052938 · Cited by 27
Malignant Syphilis: A Systematic Review of the Case Reports Published in 2014-2018
Wibisono, O., Idrus, I., & Djawad, K. (2021) · Actas Dermo-Sifiliográficas (English Edition) · doi:10.1016/j.adengl.2021.05.014 · Cited by 26
The Prozone Phenomenon in Syphilis Testing
Geisler, W. M. (2004) · Southern Medical Journal · doi:10.1097/01.smj.0000092571.52330.13 · Cited by 26
Ren, R.-X., Wang, L.-N., Zheng, H.-Y., & Li, J. (2016) · International Journal of STD & AIDS · doi:10.1177/0956462415573677 · Cited by 23
CROWE, G., THEODORE, C., FORSTER, G. E., & GOH, B. T. (1997) · Sexually Transmitted Diseases · doi:10.1097/00007435-199703000-00002 · Cited by 22
Antonio, M. B., Cuba, G. T., Vasconcelos, R. D. P., Alves, A. P. P. D. S., da Silva, B. O., & Avelino‐Silva, V. I. (2018) · AIDS · doi:10.1097/qad.0000000000001975 · Cited by 19
Nieuwenburg, S. A., Sprenger, R. J., Schim van der Loeff, M. F., & de Vries, H. J. C. (2022) · Sexually Transmitted Infections · doi:10.1136/sextrans-2020-054887 · Cited by 16
Secondary pulmonary syphilis: Case report and review of literature
Youssef, H. K., Blind, A., Ngaha, F. C., Drénou, B., Nojavan, H., & Michel, C. (2018) · Annales de Dermatologie et de Vénéréologie · doi:10.1016/j.annder.2017.11.015 · Cited by 16
Osbak, K. K., Tsoumanis, A., De Baetselier, I., Van Esbroek, M., Smet, H., Kenyon, C. R., & Crucitti, T. (2020) · BMJ Open · doi:10.1136/bmjopen-2019-035838 · Cited by 15
Otosyphilis: missed opportunities for early treatment?
Bradshaw, D., Pallawela, S., Nelson, M., Scott, C., & Day, S. (2012) · Sexually Transmitted Infections · doi:10.1136/sextrans-2012-050792 · Cited by 14 · cited 1×
“78 · If otosyphilis is suspected, immediate referral to and management in collaboration with an audiologist or ear, nose and throat specialist is important.”
BackgroundCosta‐Silva, M., Azevedo, C., Azevedo, F., & Lisboa, C. (2016) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.13766 · Cited by 14
Clinical Evaluation of Amoxycillin in the Treatment of Syphilis
Onoda, Y. (1979) · Journal of International Medical Research · doi:10.1177/030006057900700612 · Cited by 12
Pastuszczak, M., Kotnis-Gąska, A., Jakubowicz, B., Martyka, I., Bociaga-Jasik, M., & Wojas-Pelc, A. (2018) · International Journal of STD & AIDS · doi:10.1177/0956462418762849 · Cited by 11
Is it useful to perform a chest X-ray in asymptomatic patients with late latent syphilis?
Dabis, R., & Radcliffe, K. (2011) · International Journal of STD & AIDS · doi:10.1258/ijsa.2010.010248 · Cited by 10
Dabis, R., & Radcliffe, K. (2012) · International Journal of STD & AIDS · doi:10.1258/ijsa.2012.012191 · Cited by 10
Deciphering the serological response to syphilis treatment in men living with HIV
Ren, M., Szadkowski, L., & Walmsley, S. L. (2020) · AIDS · doi:10.1097/qad.0000000000002656 · Cited by 10 · cited 1×
“128,141,142 · People living with HIVon ART have reduced serological failure rates.”
BackgroundPetersen, J., Gibin, M., Sile, B., & Simms, I. (2016) · Sexually Transmitted Infections · doi:10.1136/sextrans-2015-052306 · Cited by 9
Allen, H., Kirwan, P., Brown, A. E., Mohammed, H., Hughes, G., Marks, M., & Delpech, V. (2021) · Sexually Transmitted Infections · doi:10.1136/sextrans-2020-054603 · Cited by 9
Asymptomatic Neurosyphilis After Doxycycline Therapy for Early Latent Syphilis
ZENILMAN, J. M., RAND, S., BARDITCH, P., & ROMPALO, A. M. (1993) · Sexually Transmitted Diseases · doi:10.1097/00007435-199320060-00009 · Cited by 9
Nishiki, S., Arima, Y., Kanai, M., Shimuta, K., Nakayama, S.-I., & Ohnishi, M. (2020) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2020.05.022 · Cited by 8 · cited 1×
“115 – 117 · Treatment of neurosyphilis in patients with signi fi cant penicillin allergy is challenging, and penicillin desensi-tisation is probably the best option.”
BackgroundUse of Oral Fluid With a Rapid Treponemal Test for Syphilis Evaluation
Bristow, C. C., Shannon, C., Herbst de Cortina, S., & Klausner, J. D. (2018) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000000840 · Cited by 5
Research works printed but not linked: 26
- Schaudinn F, 1905, Arb Kaiserl Gesurndheisamte, 22, 527
- Schober PC, 1983, Br J Vener Dis, 59, 217
- Anderson J, 1989, Genitourin Med, 65, 239
- Centers for Disease Control and Prevention, 2004, Morb Mortal Wkly Rep, 53, 966
- Prochazka M, Tracking the syphilis epidemic in England: 2010 to 2019. January 2021
- Gjestland T, 1955, Acta Derm Venereol Suppl, 35, 3
- Page M, 2020, Sex Transm Infect, 97, 1
- Larsen SA, 1985, Advances in sexually transmitted diseases, 157
- Izzat NN, 1971, Br J Vener Dis, 47, 162
- Idsoe O, 1972, Bull World Health Organ, 47, 1
- Polnikorn N, 1980, Br J Vener Dis, 56, 363
- Goldmeier D, 1981, Pharmatherapeutica, 3, 14
- Goh BT, 1984, Br J Vener Dis, 60, 371
- Harshan V, 1982, Indian J Dermatol, 27, 119
- Xiao H, 2017, Acta Dermatovenerol Croat, 25, 107
- Steele RW, 1984, Am J Med, 77, 50
- Katsambas A, 1987, Chemioterapia, 6, 549
- Gudjonssen H, 1968, Acta Derm Venereol, 48, 15
- Graciansky PD, 1961, Br J Vener Dis, 37, 247
- Fathilah J, 2003, Med J Malaysia, 58, 437
- Weiner AL, 1951, Ohio Med, 47, 720
- Perdrup A, 1960, Acta Derm Venereol, 40, 340
- Dai T, 2016, Antimicrob Agents Chemother, 61, e01092
- Goldman JN, 1970, Trans Am Acad Ophthalmol Otolaryngol, 74, 509
- Morrison RE, 1985, Genitourin Med, 61, 359
- Patel IH, 1984, Am J Med, 77, 17
Cited by
Acosta-Enriquez, B. G., Huamaní Jordan, O., Morales-Angaspilco, J. E., Campoverde Ventura, G., Ruiz Carrillo, J. A., Blanco- García, L. E., & Huaranga Rivera, L. (2025) · Computers in Human Behavior Reports · doi:10.1016/j.chbr.2025.100829 · Cited by 11
Sethi, V., & Marks, M. (2025) · Current Opinion in Neurology · doi:10.1097/wco.0000000000001404 · Cited by 15
Marra, C. M. (2025) · Brain · doi:10.1093/brain/awaf329 · Cited by 23
Minter, D. J., & Chow, F. C. (2025) · Annals of Neurology · doi:10.1002/ana.78016 · Cited by 12
“25 Data for this approach are quite limited and rely primarily on small retrospective series in patients with neurosyphilis and ocular syphilis.”
Separating Infectious Proctitis from Inflammatory Bowel Disease—A Common Clinical Conundrum
Hall, R., Patel, K., Poullis, A. P., Pollok, R., & Honap, S. (2024) · Microorganisms · doi:10.3390/microorganisms12122395 · Cited by 4
“The treatment of syphilis is with a single intramuscular injection of penicillin G benzathine, 2.4 million units; alternative antibiotics are doxycycline or ceftriaxone [96,106].”
Influential
Metadata
- Authors
- Kingston, M., Apea, V., Evans, C., Fifer, H., Foster, K., Patrick, P., Grant, A., Manns, V., Ramsden, S., Sinka, K., Sukthankar, A., Sullivan, A., & Tyler, S.
- Affiliations
- Manchester University NHS Foundation Trust (GB)
- Barts Health NHS Trust (GB)
- Chelsea and Westminster Hospital NHS Foundation Trust (GB)
- UK Health Security Agency (GB)
- Central and North West London NHS Foundation Trust (GB)
- Guy's and St Thomas' NHS Foundation Trust (GB)
- Churchill Hospital (GB)
- Bolton NHS Foundation Trust (GB)
- Corresponding author
- Kingston, Margaret
- Venue
- International Journal of STD & AIDS
- Publisher
- SAGE Publications
- Published
- 2024-09-13
- Volume
- 35
- Issue
- 14
- Pages
- 1142-1160
- ISSN
- 0956-4624 (ISSN-L)
- 1758-1052
- OpenAlex
- W4402545336
- Semantic Scholar
- 4da44a4a295d69dba66d0a7ee651a686accb0df2
- Cited by
- 51
- References
- 124
- Citations by year
- 2026: 31 · 2025: 19 · 2024: 1
- FWCI
- 14.40
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- International Journal of STD & AIDS (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Syphilis Diagnosis and Treatment
- Health Sciences › Medicine › Pharmacology (medical) › Historical Medical Research and Treatments
- Life Sciences › Immunology and Microbiology › Parasitology › Vector-borne infectious diseases
- Keywords
- syphilis, syphilis management, pregnant people, children, sexually transmitted infections, treatment guidelines
- MeSH terms
- Anti-Bacterial Agents, Child, Female, United Kingdom, Humans, Pregnancy, Pregnancy Complications, Infectious, Syphilis, Syphilis Serodiagnosis, Treponema pallidum
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.